New treatments for type 2 diabetes in the UK - An evolving landscape

New classes of treatments for type 2 diabetes have been developed recently and are now available in the UK. This review aims to summarise key clinical efficacy, tolerability and safety data for these agents, including liraglutide, which has received preliminary review by the National Institute for Clinical Excellence (NICE) and was launched in the UK in 2009.